AICDA and neoplasm: AID is necessary for the physiological somatic hypermutation (SHM) and class switch recombination (CSR) of immunoglobulin (Ig) genes, and it is now known that AID also causes pathogenic off-target mutations to many other genomic loci [5], [13] and results in tumor development [14], [15], [16] and progression [17].